November 28, 2024 - 18:05
Recent research from Karolinska Institutet has unveiled important insights into the long-term health effects of hormone therapy in transgender individuals. The study highlights that prolonged sex hormone treatment can significantly alter body composition and influence cardiovascular disease risk factors, especially among transgender men.
The findings indicate that hormone therapy leads to notable changes in fat distribution and muscle mass, which may have lasting implications on overall health. As transgender individuals undergo these treatments, monitoring body composition becomes essential to mitigate potential health risks.
Additionally, the research emphasizes the need for healthcare providers to be aware of these changes to offer tailored health advice and interventions. This study underscores the importance of comprehensive healthcare for transgender individuals, focusing not only on mental well-being but also on the physical health outcomes associated with long-term hormone therapy. As awareness grows, it becomes increasingly crucial to ensure that transgender individuals receive informed and supportive care throughout their transition journey.
